Cargando…
A tetracycline-inducible CRISPR/Cas9 system, targeting two long non-coding RNAs, suppresses the malignant behavior of bladder cancer cells
Clustered regularly interspaced short palindromic repeats (CRISPR) associated protein 9 (Cas9) technology has been applied in varied biological studies, including cancer studies. However, stable mRNA expression of Cas9 has potential risks in future gene therapy. Therefore, in the present study, a te...
Autores principales: | Peng, Lu, Pan, Peng, Chen, Jinbu, Yu, Xueyuan, Wu, Jun, Chen, Yong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6126189/ https://www.ncbi.nlm.nih.gov/pubmed/30214566 http://dx.doi.org/10.3892/ol.2018.9157 |
Ejemplares similares
-
Inhibition of long non-coding RNA UCA1 by CRISPR/Cas9 attenuated malignant phenotypes of bladder cancer
por: Zhen, Shuai, et al.
Publicado: (2016) -
CRISPR/Cas9 in Gastrointestinal Malignancies
por: Jefremow, André, et al.
Publicado: (2021) -
Targeting non-coding RNAs with the CRISPR/Cas9 system in human cell lines
por: Ho, Tsui-Ting, et al.
Publicado: (2015) -
Targeting cellular mRNAs translation by CRISPR-Cas9
por: Liu, Yuchen, et al.
Publicado: (2016) -
WU-CRISPR: characteristics of functional guide RNAs for the CRISPR/Cas9 system
por: Wong, Nathan, et al.
Publicado: (2015)